<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=791414221315877&amp;ev=PageView&amp;noscript=1">

Med-X Company Updates

« Go back to Blog Articles

Nick Phillips

Nick Phillips

Recent Posts

NEW: 3-5-2021 - Momentum for Med-X Continues to Grow on Multiple Fronts as Investment Banks Get More Involved

Posted by Nick Phillips on Mar 5, 2021 2:30:00 PM
In this company video update President and COO, Matthew Mills discusses the company's continued progress with E-Commerce distribution as well as the momentum that continues building with multiple investment banking opportunities including a new promising investment banker / broker-dealer relationship.
Read More

Topics: Med-X

 

Update: 1-22-2021 - Nature-Cide Begins Movement Into Mexico and Australia

Posted by Nick Phillips on Jan 22, 2021 5:02:50 PM
In this video update on January 22,  2021, COO and President, Matthew Mills reports to all shareholders on the revenue momentum that is carrying over into 2021. He explains in detail why the Company is having its best January in its history as well as discusses some exciting news in regarding the details, including our new relationships that are bringing the Nature-Cide products into Mexico, Australia, Sri Lanka and the Caribbean.  There are a lot of moving parts with this business, so please watch the video and check the news and updates section in your investor dashboard regularly, as communications will be increasing as the Company moves forward.   We are excited to report that revenue is exceeding our expectations already this year. This is the best start to a year the Company has had and we are hopeful this is setting the tone for the rest of the year.
Read More

Topics: Med-X

 

12-28-2020 - Med-X, Inc. Grows in 2020 with Essential Products, Reaches 1 Million in Revenue and Gears up to Continue Expansion in 2021

Posted by Nick Phillips on Dec 28, 2020 5:18:59 PM
In this video update, COO and President, Matthew Mills reviews the year-end Company progress and outlines how this momentum will potentially set the Company up in 2021. 2020 was a challenging year for everyone including Med-X. We faced all the challenges head-on and even during this global pandemic, of the likes few living people have ever endured, we still balanced the Company and grew revenue to over 1 million dollars. 
Read More

Topics: Med-X

 

Special Message from COO Matthew Mills: All Shareholders Need to Get Organized and Get Involved as the Company Growth Plan and Strategy Continues

Posted by Nick Phillips on Nov 20, 2020 5:19:00 PM
In this video to all Med-X shareholders, President and COO, Matthew Mills gets up close and personal and discusses how all investors need to be organized and involved in the direction of the Company, as it accelerates into 2021.  As Matthew discusses the various entities that are aligning with the Company and its multiple divisions, he is reminded of, and shares the past experience of a pathway of a previous public listing, and makes it very clear that ALL shareholders need to make sure their online portal dashboard accounts are in order.  Additionally, the Company management team and general counsel are preparing and organizing the Company in a manner where a listing on a public exchange could go hand in hand with large scale financing and acquisitions during the process.  It's very clear to management that agility is everything, and a multitude of options are seemingly presenting themselves from the multiple relationships that are building up around the Company. To reiterate, this is another reason to make sure your stock account is in order.  Please watch the video before you read the rest of this.      As we continue to plan the pathway to a possible listing of the Company on a national stock exchange, we want to make it clear and keep repeating this…
Read More

Topics: Med-X

 

Over 1100 Shareholders Have Successfully Accessed Their Med-X Shareholder Dashboard

Posted by Nick Phillips on Nov 10, 2020 3:53:37 PM
In this video, COO and President, Matthew Mills updates everyone on the launch of the new shareholder dashboard.    The initial launch on Oct. 21st was a success with over 1,100 shareholders successfully verifying and gaining access to their dashboard.
Read More

Topics: Med-X

 

US Capital Global Engages With Med-X, Inc. as Strategic Advisor for 10MM Capital Formation

Posted by Nick Phillips on Oct 22, 2020 4:29:24 PM
In this video update President and COO, Matthew Mills announces the engagement with Global Capital Group, Year-to-date Revenue Numbers, and how to access the new Med-X Shareholder Dashboard.  This update is full of important information so please take the time to read the entire update.      Global private financial group, US Capital Global, headquartered in San Francisco engaged by Med-X, Inc., Los Angeles-based green technology manufacturer as a strategic advisor.
Read More

Topics: Med-X

 

Med-X Engages with Eurasian Capital to Support Planned Path to IPO

Posted by Nick Phillips on Sep 16, 2020 10:12:00 AM
In this video update, COO and President, Matthew Mills discusses a new partnership with Eurasian Capital, LLC., shipping to Southeast Asian countries, and year-to-date revenue updates.     Progress on the planning of the IPO continues to move forward. We have officially engaged with Eurasian Capital, LLC. Eurasian Capital has a proven track record of handpicking specific high growth companies and supporting their expansion plans by investing and marketing to their network of pension funds, family offices, hedge funds, private equity firms, venture funds, securities analysts (buy-side/sell-side), stockbrokers, and institutional investors.
Read More

 

Med-X Management Team Begins Planning an IPO to Support and Bolster Growth Initiatives

Posted by Nick Phillips on Jul 13, 2020 2:35:00 PM
In this important update, COO and President, Matthew Mills discusses a strategic plan to list the Company on a national exchange to support and bolster the growth of the Nature-Cide and the Thermal-Aid divisions. Matthew Mills also reports on exciting news regarding the Company’s revenue growth, progress with institutional investment firms and the status of the Nature-Cide toxicity testing. Please watch this important announcement.      With the recipe of essential products and services, growing revenue, international distribution positioning, all while negotiating with a handful of investment banking firms, the management team has decided to move forward with the plan to execute an Initial Public Offering.
Read More

Topics: Med-X

 

Med-X Launches Regulation CF Crowdfunding Offering on TruCrowd as it Continues to Grow as an Essential Supply Business

Posted by Nick Phillips on Jun 2, 2020 2:39:00 PM
In this video update, COO, Matthew Mills, updates the company shareholders on the continued growth of the Nature-Cide Professional products as well as additional growth on Amazon from our Nature-Cide Ready to Use products.  Matthew also announces the launch of an additional capital raising campaign, a Regulation CF Offering, that will offer new potential investors on the TruCrowd platform the opportunity to get involved. In addition, Matthew also discusses the recently filed 1-K Annual Report, progress with toxicity testing and the on-going efforts to bring on institutional investors to advance the company more rapidly.  The Full Regulation CF Press Release can be seen at the end of this update.
Read More

Topics: Med-X

 

SEC Extends K1 Filling Deadline Due to Covid-19

Posted by Nick Phillips on Apr 30, 2020 10:29:00 AM
To our Shareholders, In response to the COVID-19 pandemic, we want to share that our focus is on continuing to keep our shareholders informed. In that regard, the Securities and Exchange Commission (“SEC”) earlier this month announced that due to the impact of COVID-19 on businesses, it was providing Regulation A+ companies a 45-day extension to file its Form 1-K Annual Report. Because Med-X personnel and audit personnel are now working remotely as much as possible and relying on our staff to scan and email work papers and other documents, the Company’s ability to complete its audit and file the 2019 Form 1-K prior to its due date is delayed.  Notwithstanding the foregoing, the Company expects to file the 2019 Form 1-K shortly but no later than June 13, 2020 (which is 45 days from the 2019 Form 1-K’s original filing deadline of April 29, 2020).
Read More

Topics: Med-X

 

All posts
View Offering Circular
Med-X Inc.

Investment Information

If you have questions or need help during the investment process please contact us a team member is standing by if you need assistance at any time. 
Call or Text: +1 (818) 527-9966.

The Minimum Investment is $420 for 525 Shares at $.80 per share. A complimentary ceremonial certificate for your investment will be provided upon the processing of the investment. 

This offering is an SEC Qualified Regulation A+ offering under strict security & compliance requirements by FINRA and the SEC. The security of your information is very important to us and why our Investment Website is Powered by PrimeTrust. The leading digital custodian, experts in digital financial compliance and the same provider used by all major crowdfunding portals.

To make an investment you will need to provide the following information required by Anti-Money Laundering Laws. 

  • Legal Name
  • Permanent Address
  • Social Security Number
  • Credit Card or Banking Information

We are excited to have you on board.



We Accept Visa   MasterCardPowered By Prime Trust

Recent Posts

Posts by Tag

THE SECURITIES OFFERED HEREBY ARE HIGHLY SPECULATIVE. INVESTING IN SHARES OF MED-X, INC. INVOLVES SIGNIFICANT RISKS.

THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT THEIR INVESTMENT IN MED-X, INC. COULD BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET CURRENTLY EXISTS FOR THE SECURITIES AND IF A PUBLIC MARKET DEVELOPS FOLLOWING THIS OFFERING IT MAY NOT CONTINUE.

MED-X, INC. 8236 REMMET AVENUE CANOGA PARK, CA 91304 - YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

VIEW OFFERING CIRCULAR HERE

THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, MED-X, INC., ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO MED-X, INC.’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. MED-X, INC. DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

©2021 Med-X, Inc., All Rights Reserved. | Privacy Policy | Terms and Conditions
Call or Text:  +1 (818) 527-9966
Powered by Prime Trust